FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← IKT · Inhibikase Therapeutics, Inc.
424B5The Raise

Inhibikase Therapeutics, Inc. files 424B5

Filed Nov 20, 2025 · 7mo ago · Accession 0001193125-25-289894

Plain English

424B5 filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Inhibikase Therapeutics, Inc.
Ticker
IKT
CIK
1750149
Form type
424B5
Filing date
Nov 20, 2025
Report date
—
Document
d944552d424b5.htm
Size
773 KB

More from IKT

8-KExecutive Change · Bylaw AmendmentJun 29, 20268-KResults of OperationsMay 12, 202610-QThe RecordMay 12, 2026DEF 14AThe BallotApr 30, 2026DEFA14AThe BallotApr 30, 20268-KReg FD DisclosureApr 7, 2026